NNNN - Anbio Biotechnology

22.89
1.090   4.762%

Share volume: 54,490
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$21.80
1.09
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 20%
Performance
5 Days
-0.95%
1 Month
-1.59%
3 Months
-40.73%
6 Months
-50.04%
1 Year
268.60%
2 Year
296.71%
Key data
Stock price
$22.89
P/E Ratio 
N/A
DAY RANGE
$21.21 - $23.53
EPS 
N/A
52 WEEK RANGE
$5.89 - $55.65
52 WEEK CHANGE
$268.60
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$62,166
AVERAGE 30 VOLUME 
$66,010
Company detail
CEO: Michael Lau
Region: US
Website:
Employees: 27
IPO year: 2025
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our principal executive offices are located at Wilhelm Gutbrod Str 21B, 60437, Frankfurt am Main, Germany.

Recent news